Free Trial

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.08 -0.01 (-6.25%)
As of 03:54 PM Eastern

LABS vs. CRDL, RX, HLS, SUGR, TGOD, NINE, WMD, MDP, DB, and HEXO

Should you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Cardiol Therapeutics (CRDL), BioSyent (RX), HLS Therapeutics (HLS), SugarBud Craft Growers (SUGR), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), WeedMD (WMD), Medexus Pharmaceuticals (MDP), Decibel Cannabis (DB), and HEXO (HEXO). These companies are all part of the "drug manufacturers - specialty & generic" industry.

MediPharm Labs vs. Its Competitors

MediPharm Labs (TSE:LABS) and Cardiol Therapeutics (TSE:CRDL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

In the previous week, Cardiol Therapeutics had 1 more articles in the media than MediPharm Labs. MarketBeat recorded 1 mentions for Cardiol Therapeutics and 0 mentions for MediPharm Labs. MediPharm Labs' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
Cardiol Therapeutics Neutral

0.7% of MediPharm Labs shares are held by institutional investors. Comparatively, 11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Comparatively, 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

MediPharm Labs has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$39.42M0.79-C$12.05M-C$0.03-2.58
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.32

MediPharm Labs has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500.

Cardiol Therapeutics has a net margin of 0.00% compared to MediPharm Labs' net margin of -30.56%. MediPharm Labs' return on equity of -24.41% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-30.56% -24.41% -7.17%
Cardiol Therapeutics N/A -195.07%-54.15%

Summary

MediPharm Labs beats Cardiol Therapeutics on 7 of the 11 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$31.13MC$2.25BC$5.70BC$6.38B
Dividend YieldN/A2.92%3.77%6.72%
P/E Ratio-2.584.2530.8669.99
Price / Sales0.79684.80403.901,563.49
Price / Cash1.3010.3725.2283.29
Price / Book0.6811.269.514.96
Net Income-C$12.05MC$20.70BC$3.26BC$301.20M
7 Day PerformanceN/A1.18%4.49%1.05%
1 Month PerformanceN/A4.73%5.18%2.05%
1 Year PerformanceN/A3.29%31.98%27.82%

MediPharm Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.08
-6.3%
N/A+14.3%C$31.13MC$39.42M-2.58130
CRDL
Cardiol Therapeutics
N/AC$1.59
+3.2%
N/A-33.9%C$131.94MN/A-3.1220
RX
BioSyent
N/AC$11.40
flat
N/A+14.1%C$130.39MC$34.06M18.50N/ANews Coverage
HLS
HLS Therapeutics
0.4156 of 5 stars
C$5.10
+0.6%
C$4.50
-11.8%
+58.9%C$113.46MC$40.13M-5.1191News Coverage
Analyst Revision
SUGR
SugarBud Craft Growers
N/AC$13.25
-1.8%
N/A+55.9%C$90.37MC$575.64M15.9644
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940News Coverage
Gap Up
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
MDP
Medexus Pharmaceuticals
2.4273 of 5 stars
C$2.67
-2.9%
C$5.49
+105.5%
+25.5%C$59.78MC$100.25M12.7798News Coverage
Analyst Revision
Gap Up
DB
Decibel Cannabis
N/AC$0.13
+8.7%
C$0.30
+140.0%
+100.0%C$51.13MC$105.60M-12.5083,000Gap Down
High Trading Volume
HEXO
HEXO
N/AN/AN/AN/AC$38.72MC$124.10M-0.26690

Related Companies and Tools


This page (TSE:LABS) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners